Skip to Main Content
Abbreviations
++

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Abbreviation: Chapter(s): Definition:
ACOG 9,46 American College of Obstetricians and Gynecologists
ACS 41 American Cancer Society
ACTs 10 alternative and complementary therapies
AFC 18 antral follicle count
AIS 7 androgen insensitivity syndrome
AMH 18 anti-Müllerian hormone
ART 19 assisted reproduction treatment
BMD 5,13,24,25,44 bone mineral density
BMI 8,20 body mass index
BTX 37,39 botulinum toxin
BV 32 bacterial vaginosis
CAI 38 community acquired infection
CBT 33 cognitive behavioural therapy
CCCT 18 Clomiphene Citrate Challenge Test
CFU 38 colony-forming units
CI 5,16,21,23 confidence interval
CIN 41,48 cervical intraepithelial neoplasia
COC 1,5,11,16,23,25,29,32,43 combined oral contraceptive
COX 1 cyclooxygenase
COX-1 1 cyclooxygenase-1
COX-2 1,3 cyclooxygenase-2
CPP 4 Chronic pelvic pain
CT 45,47,48,49 computed tomography
D&C 14,46 dilatation and curettage
DES 14 diethylstilbestrol
DEXA 13,44 dual-energy X-ray absorptiometry
DHEA 17,30 dehydroepiandrosterone
DMPA 24,25 depot medroxyprogesterone acetate
DSM-IV 31 Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition
DVS 15 desvenlafaxine succinate
EA 2 endometrial ablation
EFORT 18 exogenous FSH ovarian reserve test
ERMD 7 exercise related menstrual dysfunction
ERPC 26 evacuation of retained products of conception
EUA 45 examination under anaesthesia
FDA 1,14,43,46 Food and Drug Administration
FIGO 45,46,48,49 International Federation of Gynaecology and Obstetrics
FSH 7,11,12,18,19,22,25 follicle-stimulating hormone
GAST 18 gonadotrophin agonist stimulation test
GnRH 1,4,5,6,7,19 gonadotrophin-releasing hormone
GnRHa 5 gonadotrophin-releasing hormone agonist
GTD 28 gestational trophoblastic disease
hCG 19,26,27 human chorionic gonadotrophin
HERS 16 Heart and Estrogen/progestin Replacement Study
HGSIL 45 high-grade squamous intraepithelial lesion
HIV 34,35,41 human immunodeficiency virus
HNPCC 50 hereditary non-polyposis colorectal cancer
HPV 41,45 human papillomavirus
HRT 2,11,12,13, 14,15, 16,17,40,42,46,50 hormone replacement therapy
HSG 18 hysterosalpingogram
HSV 35 herpes simplex virus
IBS 4 irritable bowel syndrome
IC 4,39 interstitial cystitis
ICSI 19,21 intracytoplasmic sperm injection
Ig 22 immunoglobulin
IP 49 intraperitoneal (chemotherapy)
ISVD 48 International Society for the Study of Vulvar Disease
IU 18 international units
IUCD 29 intrauterine contraceptive device
IUI 19 intrauterine insemination
IUS 1 intrauterine system
IVF 5,19,27 in vitro fertilization
LACE 46 Laparascopic Approach to Cancer of the Endometrium
LAP2 46 Laparascopic Surgery or Standard Surgery in Treating Patients with Endometrial Cancer or Cancer of the Uterus
LBC 41 liquid-based cytology
LH 7,18,22 luteinizing hormone
LNG 1,29 levonorgestrel
LNG-IUS 1,6,11,12,25 levonorgestrel-releasing intrauterine system
LUNA 3 laparoscopic uterine nerve ablation
LVSI 45,46 lymphovascular space invasion
MEA 2 microwave endometrial ablation
MPA 46 medroxyprogesterone acetate
MRI 3,4,7,22,42,45,46,48 magnetic resonance imaging
MSU 37,38 mid-stream urine
NAAT 35 nucleic acid amplification technique
NCI 43 National Cancer Institute
NICE 42 National Institute for Clinical Excellence
NIH-NIDDK 39 National Institutes of Health – National Institute of Diabetes and Digestive and Kidney Diseases
NSAID 1,3,5,6,20 non-steroidal anti-inflammatory drug
OAB 37 overactive bladder
OR 16,21 odds ratio
ORT 18 ovarian reserve test
OVVOL 18 ovarian volume
PCO 7 polycystic ovaries
PCOS 8,20,46 polycystic ovary syndrome
PEPI 42 Progestin Estrogen–Progestin Intervention
PET 45 positron emission tomography
PFMT 36 pelvic floor muscle training
PGF2 10 prostaglandin F2
PID 18,35 pelvic inflammatory disease
PMB 14 post-menopausal bleeding
PSN 3 presacral neurectomy
PMS 9 premenstrual syndrome
POC 25 progesterone-only contraception
POF 12 premature ovarian failure
PTH 13 parathyroid hormone
PUFAs 10 polyunsaturated fatty acids
PVA 6 polyvinyl alcohol
PYC 10 pycnogenol
RANKL 13 receptor activator of nuclear factor-kappa B ligand
RCT 13 randomized controlled trial
REA 2 rollerball endometrial ablation
SD 44 standard deviations
SERM 13 selective oestrogen receptor modulator
SNRI 15,36 serotonin and noradrenaline reuptake inhibitor
SPRM 6 selective progesterone receptor modulator
SSRIs 9,15,30 selective serotonin reuptake inhibitors
STIs 24,25,29,32,35,40 sexually transmitted infections
T3 28 triiodothyronine
T4 28 thyroxine
TAHBSO 46,50 total abdominal hysterectomy and bilateral salpingo-oophorectomy
TCRE 2 transcervical endometrial resection
TOP 4,23,29 termination of pregnancy
TSH 28 thyroid-stimulating hormone
TVS 11,14,22,23,26,27,43 transvaginal ultrasound scanning
TVT 36 tension-free vaginal tape
UAE 6 uterine artery embolization
UK 24,29,35,42,44 United Kingdom
UPSI 29 unprotected sexual intercourse
US 10,35 United States
UTI 38 urinary tract infection
VAC 10 vitex agnus castus
VEGF 47 vascular endothelial growth factor
VIN 48 vulvar intraepithelial neoplasia
VTE 16 venous thromboembolism
VVC 34 vulvovaginal candidiasis
WHI 13,16,42 Women's Health Initiative
WHO 18,24,25 World Health Organization
WHOMEC 25 World Health Organization Medical Eligibility Criteria for Contraceptive Use

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.